Non-alcoholic Steatohepatitis (NASH) Diagnostics Market to Witness Unprecedented Growth During Forecast Period 2032

Introducing the Most Recent Research Report [2023-2032] on the Non-alcoholic Steatohepatitis (NASH) Diagnostics Market: Size, Emerging Trends, Market Share, Remarkable Growth, Segmentation, Comprehensive Analysis, and Forward-Looking Projections for 2032. This report presents an in-depth examination of the critical drivers propelling global market sales. Within its 120 pages, the report delivers a comprehensive evaluation of the industry's current status, encompassing aspects such as market size, market share, anticipated trends, growth rate, distribution channels, and more.

The global epidemic of type 2 diabetes and rising obesity are leading to the growing prevalence of non-alcoholic steatohepatitis (NASH), especially in developed nations.

Request To Download Sample of This Strategic Report: -https://reportocean.us/sample-request/report_id/IND109

According to the NASH Education Program, NASH affects around 12% of the world's adult population. More than 80% of patients with NASH are obese, 44% have type 2 diabetes, and 72% have abnormal blood lipids (triglycerides and cholesterol). The increasing prevalence of these ailments is expected to drive the demand for NASH diagnostics over the 2018-2023 period.

Programs and initiatives to increase awareness are anticipated to bolster market growth over the forecast period. In 2016, The NASH Education Program was established with the objective of spreading awareness among medical practitioners, patients identified with NASH, and individuals at high risk of developing it. On the other hand, rising investments for the development of accurate, reliable, and readily available diagnostic tests for NASH is expected to drive the market over the forecast period.

Diagnostic techniques segment insights:

Liver biopsy is one of the broadly accepted diagnostic techniques for NASH detection since it provides accurate results. Liver biopsy is preferred by medical practitioners owing to its ability to determine the degree of steatosis and inflammation accurately. However, the invasive liver biopsy procedure has several disadvantages, such as pain, bleeding, and the possibility of injuring other organs. Thus, the adoption of non-invasive imaging techniques and biomarkers is anticipated to increase significantly. As a result, the market size of the liver biopsy technique is expected to grow at a slower rate than biomarkers, in developed regions like North America and Europe.

Regional insights:

North America held the largest share of the NASH diagnostics market. The growing prevalence of obesity and type 2 diabetes is leading to an increasing number of patients suffering from NASH in the United States (U.S.) and Canada. NASH has been reported to be the second-most common cause for liver transplantations in the U.S. By 2020, it is expected to surpass hepatitis C as the leading cause for liver transplants. Asia-Pacific is expected to be the fastest growing market owing to increasing awareness among patients and improving healthcare infrastructure. However, the high cost of NASH diagnosis through liver biopsy is restraining the growth of the market in developing regions like Latin America and Asia-Pacific.

Download Sample of This Strategic Report: -https://reportocean.us/sample-request/report_id/IND109

Companies covered:

1. GENFIT SA
2. Echosens
3. SuperSonic Imagine
4. BioPredictive
5. One Way Liver, S.L. (OWL)
6. VLVbio AB
7. Quest Diagnostics Incorporated
8. Prometheus Laboratories Inc.
9. Siemens Healthcare GmbH.
10. Exalenz Bioscience Ltd.

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

North America (U.S. & Canada)

Latin America (Brazil, Mexico, Argentina, Rest of Latin America)

Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe)

Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific)

Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa)

Request full Report Description, TOC, Table of Figure, Chart, etc. @ -https://reportocean.us/sample-request/report_id/IND109

Some Questions Answered in the Global Non-alcoholic Steatohepatitis (NASH) Diagnostics Market Report:

What is the projected size of the global Non-alcoholic Steatohepatitis (NASH) Diagnostics market in 2030, and what growth rate is expected?
What are the primary drivers of growth in the global Non-alcoholic Steatohepatitis (NASH) Diagnostics industry?
What are the major market trends that are affecting the expansion of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market?
What obstacles must be overcome in order to achieve sustained growth in the Non-alcoholic Steatohepatitis (NASH) Diagnostics market?
What opportunities and threats do vendors in the global Non-alcoholic Steatohepatitis (NASH) Diagnostics market face?
What are the raw materials and manufacturing equipment used in the production of Non-alcoholic Steatohepatitis (NASH) Diagnostics Market, and what is the manufacturing process?
What are the different types and applications of Non-alcoholic Steatohepatitis (NASH) Diagnostics Market, and what is the market share of each type and application?
What factors, such as trends, challenges, and risk factors, are currently shaping the growth of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market?
What factors are driving the growth of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market in the top regions worldwide?
Who are the major players in the global Non-alcoholic Steatohepatitis (NASH) Diagnostics market, and what strategies are they employing to succeed?
What industrial trends, drivers, and challenges are influencing the expansion of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market?
What are the main findings of a five forces analysis of the global Non-alcoholic Steatohepatitis (NASH) Diagnostics market?

Here are the key highlights of the report:

Comprehensive assessments of the market share for Invisible Braces, conducted at both country and regional levels.
In-depth analysis of the competitive landscape, identifying key trends within the industry.
Thorough examination of market trends, encompassing product and technology advancements, drivers and barriers, and an analysis based on PORTER's five forces.
Strategic recommendations tailored for crucial business segments, leveraging market forecasts.
Guidance provided for new market entrants, assisting them in navigating the industry landscape.
Market forecasts encompassing all pertinent segments, sub-segments, and regional markets.

Request Full Report -https://reportocean.us/sample-request/report_id/IND109

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today's competitive environment. Report Ocean is a 'one-stop solution' for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:
Report Ocean:
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 - UNITED STATES
Tel:+1 888 212 3539 (US - TOLL FREE)
Website: https://reportocean.us/

This release was published on openPR.